Unlisted Indian companies increasingly rely on Employee Stock Option Plans (ESOPs) with long-term performance-linked vesting to drive sustained growth, tying employee rewards to ambitious milestones like multi-year revenue targets or EBITDA growth. While abundant resources cover ESOP basics, a critical gap persists: comprehensive, India-centric guidance on navigating complex vesting schedules, performance conditions, modifications, valuations without quoted prices, and full-cycle disclosures under Ind AS 102 for unlisted entities. This detailed article fills that void, offering entrepreneurs a complete roadmap from term sheet inception to audited financials, ensuring compliance, tax efficiency, and strategic talent retention.
The Strategic Imperative of Performance-Linked ESOPs
Performance-linked ESOPs go beyond time-based grants by conditioning vesting on quantifiable achievements, such as achieving 20% CAGR in revenue over three years or surpassing EBITDA thresholds, aligning workforce efforts with shareholder value in unlisted startups, SMEs, and family businesses. This structure mitigates short-termism, with surveys indicating over 60% of unlisted tech firms incorporating such clauses to combat high attrition in competitive markets like Hyderabad's IT corridor. Unlike cash bonuses, ESOPs preserve liquidity while offering upside potential, but demand precise accounting to avoid P&L distortions or investor disputes during funding rounds.
Drafting a Robust Term Sheet
The term sheet is the blueprint, mandating clarity on all terms under Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014. Essential elements include total options (capped at 15% of post-issue paid-up capital), exercise price (often par value ₹10), vesting cliff (minimum one year from grant), exercise period (1-10 years post-vesting), and detailed performance triggers.
For long-term plans, specify tiered vesting: e.g., 30% on Year 2 revenue >₹50 Cr, 40% on Year 4 EBITDA margin >18%, balance on Year 5 total shareholder return outperforming peers. Include forfeiture rules (e.g., 100% lapse on voluntary exit pre-vesting), anti-dilution protections, and drag-along rights. Shareholder approval requires a special resolution with an explanatory statement disclosing employee categories, dilution impact, and Ind AS 102 methodology—filed via Form MGT-14 within 30 days.
Complete ESOP Lifecycle
Unlisted companies follow this phased rollout:
- Policy Formulation: Board approves draft aligned with Section 62(1)(b) of Companies Act, 2013.
- Shareholder Nod: Special resolution; nominate administrator (often trustee).
- Grant Date: Formal allotment letter; fair value fixation kicks off accounting.
- Vesting Monitoring: Quarterly reviews of performance; probability assessments.
- Exercise Window: Employee pays price; issue shares via board resolution, file Form PAS-3 with RoC within 30 days.
- Post-Exercise: Update register of members (Form SH-6); annual Directors' Report disclosures.
Long-term links (4-7 years) enhance stickiness but amplify estimation risks.
Time-Based vs Performance Vesting: Key Distinctions
Time-based plans vest purely on continued service, enabling straightforward straight-line expensing. Performance introduces nuance under Ind AS 102.
| Vesting Type | Definition & Triggers | Accounting Treatment | Revisions Allowed? | Real-World Example |
|---|---|---|---|---|
| Time-Based | Employment continuity (e.g., 25% p.a. over 4 years) | Straight-line over vesting period; actual forfeiture true-up | Only for actual forfeitures | Standard 48-month graded schedule |
| Non-Market Performance | Internal KPIs (revenue, EBITDA, headcount) | Grant-date FV × estimated vesting %; annual probability re-estimate with cumulative catch-up | Yes, full true-up each period | Vest 50% if FY3 net profit >₹20 Cr |
| Market Performance | External benchmarks (share price, TSR vs index) | FV incorporates condition probability at grant; no post-grant revision | No—locked at grant date | Full vest if FMV doubles by FY5 |
Valuing Unlisted Options: No Quoted Price Challenge
Without market quotes, engage a SEBI-registered Category-I valuer for fair market value (FMV) of underlying equity via DCF (10-year projections, WACC 12-18%), comparable company multiples (EV/EBITDA 8-15x for tech), or recent 409A-like transactions. Option FV then applies:
- Black-Scholes-Merton: For time-based; inputs: FMV ₹50, strike ₹10, volatility 50-70% (peer-derived), risk-free 6.5-7.5% (G-Sec), dividend yield 0%, life 5 years—yields ₹20-35/option.
- Binomial Lattice: Handles early exercise; granular path simulations.
- Monte Carlo Simulation: Essential for performance (10,000+ paths modeling correlated metrics); adds 10-20% premium for hurdles.
Annual refresh for non-market estimates; disclose inputs in notes.
Modifications, Cancellations, and Top-Ups
- Cancellations: Employee exits trigger immediate recognition of remaining expense (as services rendered); any exercise payment nets against equity unless exceeding recoverable FV (then P&L).
- Modifications: Repricing, extended vesting, or eased targets = incremental FV (new minus old) amortized over revised period. E.g., dropping EBITDA hurdle from 18% to 15% adds ₹2-5/option expense.
- Top-Ups/Accelerators: New grants valued independently; change-in-control often accelerates pro-rata.
| Event Type | Typical Cause | Detailed Treatment | Balance Sheet Flow | P&L Consequence |
|---|---|---|---|---|
| Cancellation | Resignation/termination pre-vest | Accelerate unamortized FV to expense; payment to equity | Reserve → Retained Earnings | Sharp one-off hit |
| Modification (Repricing) | Market downturn retention | Incremental FV over remaining life | Additional reserve buildup | Sustained uplift |
| Top-Up Grant | Performance bonus | Standalone FV, new vesting schedule | Fresh reserve entry | Parallel amortization |
| Acceleration | M&A event | Immediate full FV recognition | Bulk reserve transfer | Front-loaded expense |
Step-by-Step Journal Entries
- Grant Date: No entry; compute FV (e.g., 10,000 options @ ₹25 FV).
- Vesting Year 1 (4-year vest, 90% expected): Dr Expense ₹22,500 (10K×25×90%×25%); Cr SBP Reserve ₹22,500.
- True-Up Year 2 (now 85% expected): Dr Expense ₹28,125 (catch-up); Cr Reserve.
- Cancellation (2,000 options): Dr Expense ₹37,500 (remainder); Cr Reserve.
- Exercise (8,000 options @ ₹10 strike): Dr SBP Reserve ₹160,000; Dr Cash ₹80,000; Cr Share Capital ₹80,000; Cr Securities Premium ₹160,000.
Post-vesting lapses hit equity directly—no P&L.
Mandated Disclosures: Sample Note to Accounts
Ind AS 102 requires exhaustive notes. Here's a production-ready template:
Note 42: Share-based Payments (₹ in crores)
Nature: Long-term ESOPs vesting on combined service (4 years min), non-market (EBITDA CAGR >15%), and market (FMV >2x grant) conditions. Plan administered by XYZ Trustees.
Reconciliation of Options:
| Particulars | 31-Mar-2026 | 31-Mar-2025 | Weighted Avg Exercise Price (₹) | Weighted Avg Remaining Life (Years) |
|---|---|---|---|---|
| Outstanding - Opening | 1,00,000 | 80,000 | 10 | 3.5 |
| Granted during year | 20,000 | 30,000 | 12 | 4.0 |
| Forfeited/Lapsed | (10,000) | (5,000) | 11 | - |
| Exercised | - | (5,000) | 9 | - |
| Outstanding - Closing | 1,10,000 | 1,00,000 | 10.5 | 3.2 |
| Exercisable - Closing | 40,000 | 30,000 | 10 | 2.0 |
Total expense: ₹5.2 (PY ₹4.1). Valuation: Monte Carlo model; inputs—FMV ₹50, volatility 55%, risk-free rate 6.8%, expected life 4 years, forfeiture rate 10%. Sensitivity: ±10% volatility alters FV by 8-12%.
Directors' Report must list grants by price range, exercises, and lapses.
Cap Table Dynamics and Balance Sheet Ripple
ESOPs dilute ownership but fortify equity. Starting cap table: 10M shares (Founders 70%, Investors 25%, Others 5%).
Grant 1M options (10% pool); assume 80% vest/exercise at ₹20Cr total FV:
| Stakeholder Group | Pre-ESOP Shares | Pre % | Post-Vesting Shares | Post-Vest % | Post-Exercise Shares | Post-Ex % (Reserve +₹20Cr) |
|---|---|---|---|---|---|---|
| Founders | 7M | 70 | 7M | 63.6 | 7M | 58.3 |
| Investors | 2.5M | 25 | 2.5M | 22.7 | 2.5M | 20.8 |
| Employees | 0 | 0 | 0.8M | 7.3 | 0.8M (+1M new) | 15.0 |
| Others | 0.5M | 5 | 0.5M | 4.5 | 0.5M | 4.2 |
| Total | 10M | 100 | 11.1M | ~100 | 12.1M | 100 |
Balance Sheet: Expense reduces retained earnings (P&L), but SBP reserve swells equity—no net worth drop. EPS dilutes pre-exercise; track via Carta/Qapita for diligence.
Full Compliance Framework and Tax Angles
- Legal: Section 62(1)(b); no SEBI for unlisted; trust optional but recommended.
- Filing: PAS-3 (allotment), MGT-14 (resolution), AOC-4 (annual).
- Tax: Perquisite on exercise (FMV - strike, taxed at slab); capital gains on sale (LTCG if >24 months).
- Audit: Valuer certificate; management estimates tested.
Best Practices:
- Forecast 20-30% forfeiture; stress-test scenarios.
- Board oversight committee for grants/modifications.
- Employee comms on dilution/value.
- Integrate with ESOP software for real-time cap table.
By mastering this spectrum, Indian unlisted firms transform ESOPs into a 20-30% cheaper talent magnet, fuelling long-term outperformance while sidestepping common pitfalls like expense under-accrual or disclosure lapses.